BENITEC BIOPHRM (BNTC)
$11.80
0.62 (5.25%)
BNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024
BNTC stock results show that Benitec Biopharma missed analyst estimates for earnings per share the third quarter of 2024.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$12.71
Market Cap
298.07M
PE Ratio
-8.33
EPS
-1.4174
Volume (Avg. Vol.)
32,284
Day's Range
$11.84 - $12.90
52-Week Range
$4.26 - $13.29
Dividend & Yield
N/A (N/A)